The H-ras oncogene product p21 and prognosis in human breast cancer D. M. A. WatsonR. A. EltonW. R. Miller Report Pages: 161 - 169
Concomitant adjuvant chemotherapy and radiotherapy for high risk breast cancer patients R. HansenB. EricksonT. Anderson Report Pages: 171 - 177
Kinetic and morphometric responses of heterogeneous populations of NMU-induced rat mammary tumor cells to hormone and antipolyamine therapyin vivo Andrea ManniScott LancasterLaurence Demers Report Pages: 179 - 186
Selectivity of polyamine involvement in hormone action on normal and neoplastic target tissues of the rat Andrea ManniBetty BadgerLaurence Demers Report Pages: 187 - 196
Multiple actions of synthetic ‘progestins’ on the growth of ZR-75-1 human breast cancer cells: Anin vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids Richard PoulinDenis BakerFernand Labrie Report Pages: 197 - 210
Epidermal growth factor receptor assay: Validation of a single point method and application to breast cancer J. L. FormentoM. FrancoualG. Milano Report Pages: 211 - 219
The influence of growth factors on the proliferative potential of normal and primary breast cancer-derived human breast epithelial cells Stephen P. EthierRochelle M. SummerfeltBonnie B. Asch Report Pages: 221 - 230
An efficient method for culturing human breast carcinoma to evaluate antiblastic drug activityin vitro: Experience on 136 primary cancers and on 116 recurrences Wainer ZoliAnnalisa VolpiDino Amadori Report Pages: 231 - 238
Loss of basal cell phenotype with acquisition of lung-colonizing capability in mouse mammary tumors Airo TsuburaToshihiko InuiAkio Matsuzawa Brief communication Pages: 239 - 243
Standardized axillary dissection: Specimen weight and nodal content in breast cancer F. Hartveit Brief communication Pages: 245 - 246
